AbbVie | ABBV - Current Liabilities

Stock Price
225.64
Daily Change
2.63 1.18%
Monthly
2.48%
Yearly
18.67%
Q1 Forecast
216.14

AbbVie reported $39.39B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Abbott USD 14.58B 1.14B Sep/2025
ALKERMES USD 474.36M 31.6M Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
AstraZeneca USD 34.05B 518M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Eisai JPY 378.25B 33.36B Sep/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Merck USD 28.63B 2.59B Sep/2025
Neurocrine Biosciences USD 638M 91.7M Sep/2025
Novartis USD 32B 286M Sep/2025
Pacira USD 107.08M 206.09M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
Vertex Pharmaceuticals USD 4.48B 336.9M Sep/2025
Zoetis USD 1.81B 1.56B Sep/2025